| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -6.05M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NVCT returned +250.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +218.7% |
| 1 year | +250.2% |
| All-time high | $24.06 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NVCT would be worth today ›No. Nuvectis Pharma, Inc. has not paid a dividend in the past 12 months.
Nuvectis Pharma, Inc. stock trades on NASDAQ under the ticker symbol NVCT.
Nuvectis Pharma, Inc. is part of the Healthcare sector.
Nuvectis Pharma, Inc. has a market cap of 783.91M USD, based on the latest quote.
Nuvectis Pharma, Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
